Commonwealth Equity Services’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,486
| Closed | -$15K | – | 4229 |
|
|
2024
Q4 | $15K | Buy |
1,486
+6
| +0.4% | +$61 | ﹤0.01% | 4053 |
|
|
2024
Q3 | $18K | Sell |
1,480
-200
| -12% | -$2.43K | ﹤0.01% | 4004 |
|
|
2024
Q2 | $22K | Sell |
1,680
-14
| -0.8% | -$183 | ﹤0.01% | 3963 |
|
|
2024
Q1 | $38K | Buy |
+1,694
| New | +$38K | ﹤0.01% | 3922 |
|
|
2022
Q4 | – | Sell |
-678
| Closed | -$55K | – | 3752 |
|
|
2022
Q3 | $55K | Sell |
678
-188
| -22% | -$15.3K | ﹤0.01% | 3474 |
|
|
2022
Q2 | $58K | Sell |
866
-7
| -0.8% | -$469 | ﹤0.01% | 3464 |
|
|
2022
Q1 | $96K | Sell |
873
-40
| -4% | -$4.4K | ﹤0.01% | 3501 |
|
|
2021
Q4 | $88K | Buy |
913
+64
| +8% | +$6.17K | ﹤0.01% | 3482 |
|
|
2021
Q3 | $74K | Buy |
+849
| New | +$74K | ﹤0.01% | 3457 |
|
|
2021
Q1 | – | Sell |
-676
| Closed | -$156K | – | 3435 |
|
|
2020
Q4 | $156K | Buy |
+676
| New | +$156K | ﹤0.01% | 2982 |
|
|
2020
Q1 | – | Sell |
-670
| Closed | -$192K | – | 2898 |
|
|
2019
Q4 | $192K | Sell |
670
-192
| -22% | -$55K | ﹤0.01% | 2629 |
|
|
2019
Q3 | $124K | Buy |
+862
| New | +$124K | ﹤0.01% | 2642 |
|